Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Famar has announced the planned acquisition of the Pointe-Claire, Quebec, a manufacturing site from the Consumer Health Division of Bayer.
read more
Thursday, December 09, 2021
Fareva and ApiJect Systems, Corp. have announced a 10-year licensing agreement to install three Blow-Fill-Seal production lines that when operational will be able to fill-finish more than 500 million doses per year of vaccines and other large ...
read more
Fareva announced the opening of a new GMP Pilot Unit at its Pau site dedicated to the production of liquid and lyophilized injectable forms.
read more
Thursday, October 20, 2022
Farmabios, Novasep and PharmaZell officially announced that they are coming together under the new brand Axplora.
read more
Monday, September 30, 2019
Fate Therapeutics has opened its cGMP compliant manufacturing facility for the clinical production of its off-the-shelf natural killer cell and chimeric antigen receptor (CAR) T-cell product candidates.
read more
Thursday, August 30, 2018
Faubel and ELPRO have announced a new joint temperature monitoring system.
read more
Aralez Pharmaceuticals has announced that the U.S. Food and Drug Administration ("FDA") has acknowledged acceptance of the New Drug Application ("NDA") for its investigational candidate, YOSPRALA™(PA32540/PA8140) for the secondary prevention of ...
read more
Wednesday, September 02, 2015
Bristol-Myers Squibb announced that the FDA has accepted for filing and review the supplemental Biologics License Application (sBLA) for Opdivo for the treatment of previously treated patients with non-squamous (NSQ) non-small cell lung cancer (NSCLC...
read more
Tuesday, December 29, 2015
Epizyme, Inc., has announced that the U.S. Food and Drug Administration’s (FDA) Division of Hematology Products has accepted the company’s investigational new drug (IND) application for tazemetostat for the treatment of adults with diffuse large B-...
read more
Wednesday, November 18, 2015
Sandoz, a Novartis company, has announced today the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) under the 351 (k) pathway for its proposed biosimilar to Amgen's US-licensed Neulasta® (pegfilgrastim)* - a...
read more
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for OFEV (nintedanib), investigating a potential treatment for children and adolescents between 6 to 17 years old ...
read more
Wednesday, September 16, 2015
NVS Influenza Vaccines, now owned and operated by the CSL Limited, announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted to recommend licensure of a candidate ...
read more
The FDA is alerting API repackagers and distributors, finished drug manufacturers, and compounders that Sichuan Friendly is recalling certain lots of porcine thyroid API due to inconsistent quality of the API.
read more
Wednesday, October 14, 2015
The FDA is alerting health care professionals and patients of a voluntary recall of lots 1 through 67 of non-expired drug products intended to be sterile produced and distributed nationwide by Qualgen LLC, in Edmond, Okla., due to lack of sterility ...
read more
The FDA took two significant actions in the agency’s ongoing and aggressive commitment to address the coronavirus outbreak (COVID19).
read more